“adage-capital-management” Archives

in
Entry Author Date Location
Precision Bio Lands $110M as Gene-Edited Cell Therapy Nears Clinic 06/27/18 Raleigh Durham
Prevail Gets $75M For Parkinson’s Gene Therapy, Bolstering NY Biotech 03/08/18 New York
AppDynamics Obtains $158,000,000 New Round 11/30/15 San Francisco
AveXis Obtains $65,000,000 Series D Round 09/09/15 Texas
Protagonist Therapeutics Secures $40,000,000 Series C Funding Round 07/20/15 San Francisco
East Coast Biotech Roundup: Sync Project, Epizyme, Bristol & More 03/16/15 Boston
East Coast Biotech Roundup: Biogen, Civitas, Rhythm, Alkermes, & More 08/29/14 Boston
Shire Pays Over $260M Upfront in IPO Detour for San Diego’s Lumena 05/12/14 National
San Diego’s Lumena Files for IPO to Fund Liver Drug Trials 04/04/14 San Diego
San Diego Life Sciences Roundup: Zogenix, Ignyta, AnaptysBio, & More 03/17/14 San Diego
Lumena Pharmaceuticals Receives $45,000,000 Series B Financing Round 03/11/14 San Diego
ZS Pharma Secures $55,000,000 Series D Financing Round 03/06/14 Texas
Calithera Biosciences Garners $35,000,000 Series D Funding Round 10/25/13 San Francisco
Ultragenyx Pharmaceutical Obtains $75,000,000 Series B Round 12/20/12 San Francisco
Puma Biotechnology Lands $55,000,000 New Financing Round 10/05/11 San Diego
Biogen Idec Makes Controversial Tysabri Decision, Boston Scientific Explains Stock Sales, Charles River Heads to China, & More Boston-Area Life Sciences News 10/16/08 Boston
Concert Pharmaceuticals, Flush With Well-Timed Venture Round, Aims for Hot Flashes, HIV 10/14/08 Boston
Concert Pharmaceuticals Enters Clinical Trials with Drug for Hot Flashes 09/25/08 Boston
Portola Pharmaceuticals Lands $60,000,000 New Round 07/09/08 San Francisco
Concert Strikes a Chord With Investors, Abiomed Scores a Win with Medicare, Epix Snags $7.5M from GSK, & More Life Sciences News 05/07/08 Boston
Mascoma Teams with GM, Moldflow Melds with Autodesk, Concert Scores Some Heavy-Duty Cash, & More Deals News 05/05/08 Boston
Heavyweight Hydrogen Takes $37 Million Prize for Concert Pharmaceuticals 05/01/08 Boston
Concert Pharmaceuticals Garners $37,000,000 Series C Funding 04/30/08 Boston
Page 1 of 1